Bioventus has introduced several new products at the 2016 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
These include CellXtract, a novel cell and bone marrow extraction tool; and Signafuse bioactive bonegraft putty, which is comprised of a bi-phasic mineral composite combined with a patented bioactive glass and resorbable polymer carrier providing surgeons with exceptional handling properties.
“Bioventus is very pleased to introduce a full portfolio of bone grafting solutions backed by clinical and technical data to benefit patients, surgeons, and hospitals this week at AAOS,” says Tony Bihl, chief executive officer, Bioventus. “It’s our goal to provide customers with leading orthobiologic products that heal patients quickly and safely while helping them resume and enjoy active lives.”
